| Trial ID: | L0418 |
| Source ID: | ChiCTR2000035899
|
| Associated Drug: |
caffeic acid
|
| Title: |
Efficacy and safety of caffeic acid in nonalcoholic fatty liver disease: a randomized placebo-controlled study
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
non-alcoholic fatty liver disease
|
| Interventions: |
Experimental group:Caffeic acid tablet, 0.3g tid po.; Control group:Placebo;
|
| Outcome Measures: |
Controlled attenuation parameters(CAP);liver function test;Fasting blood glucose;blood lipid;insulin;Human body index (height, weight, waist circumference, hip circumference);
|
| Sponsor/Collaborators: |
Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
|
| Gender: |
All
|
| Age: |
1865
|
| Phases: |
Phase 0
|
| Enrollment: |
Experimental group:50; Control group:50;
|
| Study Type: |
Interventional study
|
| Study Designs: |
Parallel
|
| Start Date: |
19/08/2020
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
24 August 2020
|
| Locations: |
China
|
| URL: |
http://www.chictr.org.cn/showproj.aspx?proj=58409
|
